|
Market Closed -
Nasdaq
08:00:00 19/11/25 am AEDT
|
5-day change | 1st Jan Change | ||
| 42.98 USD | +0.35% |
|
-.--% | - |
| 19/05 | Endologix LLC acquired Pounce? Thrombectomy System from Surmodics, Inc. | CI |
| 10/12 | Surmodics, Inc. acquired certain assets from Biocoat, Incorporated. | CI |
Chart calendar SurModics
Upcoming events on SurModics
No events available
Past events on SurModics
Annual results
| Fiscal Period | September | 2022 | 2023 | 2024 |
|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 100,0 98,0 1.94% | 133 131 1.3% | 126 123 2.3% |
|
EBITDA Million USD | Released Forecast Spread | -12,9 -14,9 13.45% | 13,9 9,20 50.8% | 14,7 10,9 35.83% |
|
EBIT Million USD | Released Forecast Spread | -22,1 -24,5 9.67% | 5,60 1,59 251.84% | -5,65 -8,79 35.8% |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -22,5 -24,7 8.84% | 2,49 -1,61 254.26% | -7,51 -11,4 33.9% |
|
Net income Million USD | Released Forecast Spread | -27,3 -19,9 -36.91% | -1,54 -6,37 75.87% | -11,5 -13,2 12.31% |
|
EPS USD | Released Forecast Spread | -1,96 -1,44 -36.59% | -0,11 -0,45 75.56% | -0,82 -0,93 11.51% |
| Announcement Date | 09/11/22 | 08/11/23 | 06/11/24 |
Quarterly results
| Fiscal Period | June | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 | 2025 Q3 |
|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 30,6 29,6 3.06% | 32,0 28,8 10.8% | 30,3 30,0 1.12% | 33,2 30,4 9.32% | 29,9 33,4 -10.32% | 28,1 32,2 -12.86% | 29,6 28,1 5.39% |
|
EBITDA Million USD | Released Forecast Spread | 1,97 0,45 337.21% | 4,81 0,03 15755.59% | 1,61 0,64 153.18% | 4,39 0,50 774.28% | 3,64 3,09 17.79% | 1,94 2,43 -20.47% | 3,43 1,26 172.98% |
|
EBIT Million USD | Released Forecast Spread | -0,32 -3,79 91.51% | 0,66 -4,36 115.11% | -5,37 -4,16 -29.11% | -0,61 -3,75 83.65% | -2,48 -1,72 -44.02% | -4,01 -1,80 -122.74% | -5,24 -4,78 -9.64% |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -0,72 -4,49 83.89% | 0,17 -5,26 103.15% | -5,81 -5,34 -8.79% | -1,14 -4,97 77.1% | -2,94 -2,52 -16.7% | -4,68 -2,55 -83.58% | -5,93 -5,61 -5.76% |
|
Net income Million USD | Released Forecast Spread | -0,79 -5,13 84.69% | 0,25 -5,56 104.44% | -7,55 -5,57 -35.62% | -3,45 -5,06 31.9% | -3,65 -2,35 -55.41% | -5,21 -2,34 -122.67% | -5,32 -4,80 -10.85% |
|
EPS USD | Released Forecast Spread | -0,06 -0,36 83.45% | 0,02 -0,40 105.06% | -0,53 -0,39 -35.9% | -0,24 -0,36 32.71% | -0,26 -0,16 -59.19% | -0,36 -0,16 -120.41% | -0,37 -0,43 12.94% |
| Announcement Date | 01/02/24 | 01/05/24 | 31/07/24 | 06/11/24 | 30/01/25 | 30/04/25 | 08/08/25 |
| 17/08/2026 |  | Extraordinary General Meeting | 04:30 pm |
| 19/08/2026 | | Présentation aux Actionnaires / Analystes | 05:00 pm |
| 19/08/2026 | | Annual General Meeting | 05:00 pm |
| 20/08/2026 | | Ex-dividend date - 0.0161 GBX | 02:00 pm |
| 20/08/2026 | | Extraordinary General Meeting | 04:30 pm |
| 21/08/2026 | | Earnings release - Q2 2026 | |
| 21/08/2026 | | Board of Directors Meeting | |
| 21/08/2026 | | Earnings release - Q2 2026 | |
| 22/08/2026 | | Earnings release - Q2 2026 | |
| 22/08/2026 | | Earnings release - Q2 2026 |
Past sector events for SurModics
| 14/08/2026 | | Ex-dividend date - 0.6 USD | 02:00 pm |
| 14/08/2026 | | Ex-dividend date - 0.34 USD | 02:00 pm |
| 13/08/2026 | | Board of Directors Meeting | |
| 13/08/2026 | | Earnings presentation | 07:30 am |
| 13/08/2026 | | Earnings release - Q2 2026 | |
| 12/08/2026 | | Earnings presentation | 10:00 pm |
| 12/08/2026 | | Earnings release - Q3 2026 | |
| 12/08/2026 | | Earnings presentation | 07:00 pm |
| 11/08/2026 | | Earnings release - Q2 2026 | |
| 11/08/2026 | | Earnings release - Q1 2027 |
- Stock Market
- Stocks
- SRDX Stock
- Calendar SurModics
Select your edition
All financial news and data tailored to specific country editions
